Milestone Pharmaceuticals Inc [MIST] stock prices are up 11.86% to $2.17 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MIST shares have gain 16.67% over the last week, with a monthly amount glided 31.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Rodman & Renshaw started tracking the stock with Buy rating on August 22, 2024, and set its price target to $9. On June 20, 2023, downgrade downgraded it’s rating to Hold and revised its price target to $4 on the stock. Piper Sandler upgraded its rating to a Overweight and increased its price target to $10 on April 22, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $20 as its price target on March 05, 2021. Oppenheimer upgraded its rating to Outperform for this stock on July 29, 2020, but kept the price target unchanged to $18. In a note dated July 24, 2020, Jefferies upgraded an Buy rating on this stock.
The stock price of Milestone Pharmaceuticals Inc [MIST] has been fluctuating between $0.63 and $2.75 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $2.17 at the most recent close of the market. An investor can expect a potential return of 360.83% based on the average MIST price forecast.
Analyzing the MIST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.98 and Total Capital is -1.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-9.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.9800 points at the first support level, and at 1.8000 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.2800, and for the 2nd resistance point, it is at 2.4000.
Ratios To Look Out For
It’s worth pointing out that Milestone Pharmaceuticals Inc [NASDAQ:MIST]’s Current Ratio is 4.67. Further, the Quick Ratio stands at 4.67, while the Cash Ratio is 3.48.
